Literature DB >> 16571647

The molecular genetics of Marfan syndrome and related disorders.

P N Robinson1, E Arteaga-Solis, C Baldock, G Collod-Béroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, C M Kielty, B Loeys, D M Milewicz, A Ney, F Ramirez, D P Reinhardt, K Tiedemann, P Whiteman, M Godfrey.   

Abstract

Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated individuals with MFS is acute aortic dissection, which often follows a period of progressive dilatation of the ascending aorta. Recent research on the molecular physiology of fibrillin and the pathophysiology of MFS and related disorders has changed our understanding of this disorder by demonstrating changes in growth factor signalling and in matrix-cell interactions. The purpose of this review is to provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils. Mutations in FBN1 and other genes found in MFS and related disorders will be discussed, and novel concepts concerning the complex and multiple mechanisms of the pathogenesis of MFS will be explained.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571647      PMCID: PMC2563177          DOI: 10.1136/jmg.2005.039669

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  247 in total

Review 1.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Structure of the human gene encoding the associated microfibrillar protein (MFAP1) and localization to chromosome 15q15-q21.

Authors:  H Yeh; M Chow; W R Abrams; J Fan; J Foster; H Mitchell; M Muenke; J Rosenbloom
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

3.  Fibrillins 1 and 2 perform partially overlapping functions during aortic development.

Authors:  Luca Carta; Lygia Pereira; Emilio Arteaga-Solis; Sui Y Lee-Arteaga; Brett Lenart; Barry Starcher; Christian A Merkel; Marina Sukoyan; Alexander Kerkis; Noriko Hazeki; Douglas R Keene; Lynn Y Sakai; Francesco Ramirez
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

4.  Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome.

Authors:  M Godfrey; S Olson; R G Burgio; A Martini; M Valli; G Cetta; H Hori; D W Hollister
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

5.  Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40.

Authors:  F Tiecke; S Katzke; P Booms; P N Robinson; L Neumann; M Godfrey; K R Mathews; M Scheuner; G K Hinkel; R E Brenner; H H Hövels-Gürich; C Hagemeier; J Fuchs; F Skovby; T Rosenberg
Journal:  Eur J Hum Genet       Date:  2001-01       Impact factor: 4.246

Review 6.  Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database.

Authors:  Gwenaëlle Collod-Béroud; Saga Le Bourdelles; Lesley Ades; Leena Ala-Kokko; Patrick Booms; Maureen Boxer; Anne Child; Paolo Comeglio; Anne De Paepe; James C Hyland; Katerine Holman; Ilkka Kaitila; Bart Loeys; Gabor Matyas; Lieve Nuytinck; Leena Peltonen; Terhi Rantamaki; Peter Robinson; Beat Steinmann; Claudine Junien; Christophe Béroud; Catherine Boileau
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

7.  Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms.

Authors:  T Aoyama; U Francke; H C Dietz; H Furthmayr
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2.

Authors:  Claudio C Werneck; Barbara Crippes Trask; Thomas J Broekelmann; Timothy M Trask; Timothy M Ritty; Fernando Segade; Robert P Mecham
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  Ultrastructural immunolocalization of lysyl oxidase in vascular connective tissue.

Authors:  H M Kagan; C A Vaccaro; R E Bronson; S S Tang; J S Brody
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

10.  Abnormal fibrillin assembly by dermal fibroblasts from two patients with Marfan syndrome.

Authors:  C M Kielty; C A Shuttleworth
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

View more
  120 in total

1.  Medical treatment of crystalline lens dislocation into the anterior chamber in a patient with Marfan syndrome.

Authors:  Manuel Garza-Leon; Paola de la Parra-Colín
Journal:  Int Ophthalmol       Date:  2012-06-13       Impact factor: 2.031

Review 2.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

Review 3.  Preterm birth and single nucleotide polymorphisms in cytokine genes.

Authors:  Qin Zhu; Jian Sun; Ying Chen
Journal:  Transl Pediatr       Date:  2014-04

Review 4.  Marfanoid-progeroid-lipodystrophy syndrome: a newly recognized fibrillinopathy.

Authors:  Eberhard Passarge; Peter N Robinson; Luitgard M Graul-Neumann
Journal:  Eur J Hum Genet       Date:  2016-02-10       Impact factor: 4.246

5.  Human microvascular lymphatic and blood endothelial cells produce fibrillin: deposition patterns and quantitative analysis.

Authors:  Antonella Rossi; Erica Gabbrielli; Marilisa Villano; Mario Messina; Francesco Ferrara; Elisabetta Weber
Journal:  J Anat       Date:  2010-10-11       Impact factor: 2.610

6.  Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues.

Authors:  Russell A Norris; Brook Damon; Vladimir Mironov; Vladimir Kasyanov; Anand Ramamurthi; Ricardo Moreno-Rodriguez; Thomas Trusk; Jay D Potts; Richard L Goodwin; Jeff Davis; Stanley Hoffman; Xuejun Wen; Yukiko Sugi; Christine B Kern; Corey H Mjaatvedt; Debi K Turner; Toru Oka; Simon J Conway; Jeffery D Molkentin; Gabor Forgacs; Roger R Markwald
Journal:  J Cell Biochem       Date:  2007-06-01       Impact factor: 4.429

Review 7.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 8.  Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature.

Authors:  M Carlson; M Silberbach
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

9.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.

Authors:  Peter N Robinson; Sebastian Köhler; Sebastian Bauer; Dominik Seelow; Denise Horn; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2008-10-23       Impact factor: 11.025

10.  Villous papillary thyroid carcinoma: a variant associated with marfan syndrome.

Authors:  Daniel A Winer; Shawn Winer; Lorne Rotstein; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.